Bridgeway Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Hold |
41,000
| – | – | ﹤0.01% | 973 |
|
|
2025
Q1 | $200K | Buy |
+41,000
| New | +$200K | 0.01% | 928 |
|
|
2024
Q4 | – | Sell |
-1,160
| Closed | -$8.97K | – | 1255 |
|
|
2024
Q3 | $8.97K | Sell |
1,160
-9,700
| -89% | -$75K | ﹤0.01% | 1250 |
|
|
2024
Q2 | $65.2K | Hold |
10,860
| – | – | ﹤0.01% | 1200 |
|
|
2024
Q1 | $97.9K | Sell |
10,860
-5,000
| -32% | -$45.1K | ﹤0.01% | 1210 |
|
|
2023
Q4 | $150K | Sell |
15,860
-15,150
| -49% | -$144K | ﹤0.01% | 1186 |
|
|
2023
Q3 | $369K | Buy |
31,010
+11,460
| +59% | +$136K | 0.01% | 964 |
|
|
2023
Q2 | $479K | Buy |
+19,550
| New | +$479K | 0.01% | 915 |
|
|
2022
Q3 | – | Sell |
-2,720
| Closed | -$225K | – | 1427 |
|
|
2022
Q2 | $225K | Hold |
2,720
| – | – | 0.01% | 1066 |
|
|
2022
Q1 | $452K | Sell |
2,720
-11,540
| -81% | -$1.92M | 0.01% | 963 |
|
|
2021
Q4 | $2.38M | Sell |
14,260
-5,760
| -29% | -$963K | 0.04% | 554 |
|
|
2021
Q3 | $1.73M | Sell |
20,020
-2,500
| -11% | -$216K | 0.03% | 678 |
|
|
2021
Q2 | $1.22M | Sell |
22,520
-1,000
| -4% | -$54.3K | 0.02% | 789 |
|
|
2021
Q1 | $1.4M | Buy |
+23,520
| New | +$1.4M | 0.03% | 746 |
|
|
2020
Q2 | – | Sell |
-4,997
| Closed | -$218K | – | 1354 |
|
|
2020
Q1 | $218K | Sell |
4,997
-2,820
| -36% | -$123K | 0.01% | 1031 |
|
|
2019
Q4 | $313K | Buy |
7,817
+3,637
| +87% | +$146K | ﹤0.01% | 1106 |
|
|
2019
Q3 | $137K | Buy |
+4,180
| New | +$137K | ﹤0.01% | 1222 |
|